Akso Health Group (AHG)
Akso Health Statistics
Share Statistics
Akso Health has 79.97M shares outstanding. The number of shares has increased by 537.29% in one year.
| Shares Outstanding | 79.97M |
| Shares Change (YoY) | 537.29% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0.52% |
| Shares Floating | 144.21M |
| Failed to Deliver (FTD) Shares | 414 |
| FTD / Avg. Volume | 1.37% |
Short Selling Information
The latest short interest is 50.74K, so 0.06% of the outstanding shares have been sold short.
| Short Interest | 50.74K |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.04% |
| Short Ratio (days to cover) | 2.29 |
Valuation Ratios
The PE ratio is -1.81 and the forward PE ratio is -8.11. Akso Health's PEG ratio is 0.03.
| PE Ratio | -1.81 |
| Forward PE | -8.11 |
| PS Ratio | 7.09 |
| Forward PS | 0.5 |
| PB Ratio | 0.12 |
| P/FCF Ratio | 12.67 |
| PEG Ratio | 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Akso Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 39.52, with a Debt / Equity ratio of 0.01.
| Current Ratio | 39.52 |
| Quick Ratio | 39.46 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.24 |
| Debt / FCF | 1.48 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $268.26K |
| Profits Per Employee | $-1.05M |
| Employee Count | 9 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 11.99 |
Taxes
| Income Tax | 24.99K |
| Effective Tax Rate | -0.27% |
Stock Price Statistics
The stock price has increased by 18.63% in the last 52 weeks. The beta is -0.3, so Akso Health's price volatility has been lower than the market average.
| Beta | -0.3 |
| 52-Week Price Change | 18.63% |
| 50-Day Moving Average | 1.23 |
| 200-Day Moving Average | 1.1 |
| Relative Strength Index (RSI) | 45.07 |
| Average Volume (20 Days) | 30.22K |
Income Statement
In the last 12 months, Akso Health had revenue of 2.41M and earned -9.46M in profits. Earnings per share was -0.21.
| Revenue | 2.41M |
| Gross Profit | 122.13K |
| Operating Income | -8.64M |
| Net Income | -9.46M |
| EBITDA | -8.5M |
| EBIT | -9.09M |
| Earnings Per Share (EPS) | -0.21 |
Balance Sheet
The company has 85.17M in cash and 2M in debt, giving a net cash position of 83.17M.
| Cash & Cash Equivalents | 85.17M |
| Total Debt | 2M |
| Net Cash | 83.17M |
| Retained Earnings | -63.93M |
| Total Assets | 142.02M |
| Working Capital | 138.42M |
Cash Flow
In the last 12 months, operating cash flow was 1.35M and capital expenditures 0, giving a free cash flow of 1.35M.
| Operating Cash Flow | 1.35M |
| Capital Expenditures | 0 |
| Free Cash Flow | 1.35M |
| FCF Per Share | 0.03 |
Margins
Gross margin is 5.06%, with operating and profit margins of -357.78% and -391.78%.
| Gross Margin | 5.06% |
| Operating Margin | -357.78% |
| Pretax Margin | -376.57% |
| Profit Margin | -391.78% |
| EBITDA Margin | -352.06% |
| EBIT Margin | -357.78% |
| FCF Margin | 55.97% |
Dividends & Yields
AHG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for AHG.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 24, 2020. It was a backward split with a ratio of 1:3.
| Last Split Date | Aug 24, 2020 |
| Split Type | backward |
| Split Ratio | 1:3 |
Scores
| Altman Z-Score | 14.36 |
| Piotroski F-Score | 3 |